Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

The inhibitor affects androgen metabolism but not ovarian function.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

JAK inhibitors show promise for treating various skin diseases.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Five FDA-approved drugs may help block COVID-19 virus entry.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Six existing drugs may help block virus entry in COVID-19.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

CS12192 effectively treats alopecia areata with better safety than current options.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Baricitinib is the most effective treatment for alopecia areata.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.